BioSpace News Archive

Biotech Beach

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 01, 2022

Zentalis™ Pharmaceuticals, Inc. announced that on November 1, 2022, the Compensation Committee of Zentalis’ Board of Directors granted non-qualified stock options to purchase an aggregate of 350,025 shares of the Company’s common stock to four newly hired employees.

November 1, 2022
·
2 min read
Policy

FDA Roundup: November 1, 2022

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

November 1, 2022
·
3 min read
Business

CSL Enters Licensing Agreement with Arcturus Therapeutics for Next Generation mRNA Vaccine Technology

CSL Limited (ASX:CSL; USOTC:CSLLY) today announces that its subsidiary, CSL Seqirus, has entered into a collaboration and license agreement with Arcturus Therapeutics Holdings Inc (“Arcturus Therapeutics”) to access their late stage self-amplifying mRNA (sa-mRNA) vaccine platform technology.

November 1, 2022
·
8 min read
Business

Arcturus Announces Collaboration with CSL to Develop and Commercialize Self-amplifying mRNA Vaccines

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT) today announced a strategic collaboration with CSL Seqirus, a global vaccine leader, for the research, development, manufacture, and global commercialization of vaccines.

November 1, 2022
·
7 min read
Immutep to Participate in Two Upcoming November 2022 Investor Conferences

Immutep Limited, a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, announced that Marc Voigt, CEO will be presenting at two upcoming investor conferences.

November 1, 2022
·
1 min read
Zealand Pharma Announces Presentations at The Obesity Society Annual Meeting

Zealand Pharma A/S a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced presentations at the Obesity Society Annual Meeting being held in San Diego, California from November 1-4, 2022.

November 1, 2022
·
12 min read
Deals

Avista Capital Partners Acquires Taconic Biosciences

Avista Capital Partners, a leading private equity firm focused exclusively on healthcare, announced its acquisition of Taconic Biosciences, a leading provider of genetically engineered research models and related services, from H.I.G. Capital.

November 1, 2022
·
3 min read
BioMidwest

Tampa General Hospital is the First U.S. Emergency Department to Offer Rapid Blood Test for Concussion and Traumatic Brain Injury to Patients

Physicians at Tampa General Hospital’s emergency department are the first in the nation, outside of a clinical trial setting, to use an FDA-cleared rapid blood test to successfully evaluate patients who are 18 and older with mild traumatic brain injury, including concussions.

November 1, 2022
·
6 min read
Clinical Trial Investigative Site Network Market Size to Hit USD 12.77 BN by 2030

The global clinical trial investigative site network market was valued at USD 7.51 billion in 2021 and is expected to hit around USD 12.77 billion by 2030, growing at a CAGR of 6.08% from 2022 to 2030.

November 1, 2022
·
8 min read
BioMidwest

Pulmonary Fibrosis Foundation Expands Research Into Devastating Lung Disease

The Pulmonary Fibrosis Foundation, the nation’s leading pulmonary fibrosis research, advocacy, and education organization, has announced an increase in funding for its PFF Scholars program.

November 1, 2022
·
3 min read